Literature DB >> 15135564

The context of sexual risk behavior among heterosexual methamphetamine users.

Shirley J Semple1, Thomas L Patterson, Igor Grant.   

Abstract

Relatively little is known about the relationship between methamphetamine (meth) use and sexual risk behavior among heterosexual adults. This descriptive study explores the context of sexual risk behavior among HIV-negative, heterosexual meth-using men and women. Drug use history, motivations for meth use, relationship types, and the social-sexual context of meth use were examined as factors that relate to sexual risk behavior and meth use. The majority of participants were white males with an average age of 38.6 years. Primary motivations for current meth use were to get high, to get more energy, and to party. Participants used meth an average of 14 days per month and consumed an average of 7.9 g during this period. The average number of unprotected vaginal, anal, and oral sex acts over a 2-month period were 21.5, 6.3, and 41.7, respectively. Participants reported an average of 9.4 sex partners over 2 months. The findings are discussed in relation to HIV prevention messages and the development of sexual risk reduction interventions for HIV-negative, heterosexual meth users.

Entities:  

Mesh:

Year:  2004        PMID: 15135564     DOI: 10.1016/j.addbeh.2004.02.013

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  51 in total

1.  A Comparison of Methamphetamine Users to a Matched NHANES Cohort: Propensity Score Analyses for Oral Health Care and Dental Service Need.

Authors:  Debra A Murphy; Lauren Harrell; Rachel Fintzy; Thomas R Belin; Alexis Gutierrez; Steven J Vitero; Vivek Shetty
Journal:  J Behav Health Serv Res       Date:  2016-10       Impact factor: 1.505

2.  Neuropsychological deficits in adolescent methamphetamine abusers.

Authors:  George King; Daniel Alicata; Christine Cloak; Linda Chang
Journal:  Psychopharmacology (Berl)       Date:  2010-07-17       Impact factor: 4.530

3.  Predictors of Attrition in a Cohort Study of HIV Infection and Methamphetamine Dependence.

Authors:  J Cattie; M J Marquine; K A Bolden; L C Obermeit; E E Morgan; D R Franklin; A Umlauf; J M Beck; J H Atkinson; I Grant; S P Woods
Journal:  J Subst Use       Date:  2015-02-03

4.  Influence of aripiprazole pretreatment on the reinforcing effects of methamphetamine in humans.

Authors:  William W Stoops; J Adam Bennett; Joshua A Lile; Rajkumar J Sevak; Craig R Rush
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-08-28       Impact factor: 5.067

Review 5.  Behavior change and health-related interventions for heterosexual risk reduction among drug users.

Authors:  Salaam Semaan; Don C Des Jarlais; Rob Malow
Journal:  Subst Use Misuse       Date:  2006       Impact factor: 2.164

6.  Misuse of methamphetamine and prescription stimulants among youths and young adults in the community.

Authors:  Li-Tzy Wu; Daniel J Pilowsky; William E Schlenger; Deborah M Galvin
Journal:  Drug Alcohol Depend       Date:  2007-01-24       Impact factor: 4.492

7.  The Feasibility of Interventions to Reduce HIV Risk and Drug Use among Heterosexual Methamphetamine Users.

Authors:  Karen F Corsi; Wayne E Lehman; Sung-Joon Min; Shannon P Lance; Nicole Speer; Robert E Booth; Steve Shoptaw
Journal:  J AIDS Clin Res       Date:  2012-06-04

8.  Life events and sexual risk among HIV-negative, heterosexual, methamphetamine users.

Authors:  Shirley J Semple; Steffanie A Strathdee; Jim Zians; Thomas L Patterson
Journal:  J Sex Res       Date:  2010-07

9.  Sexual risk behaviors among club drug users in Shanghai, China: prevalence and correlates.

Authors:  Yingying Ding; Na He; Weiming Zhu; Roger Detels
Journal:  AIDS Behav       Date:  2013-09

10.  Androgen-primed castrate males are sufficient for methamphetamine-facilitated increases in proceptive behavior in female rats.

Authors:  Sarah A Rudzinskas; Jessica A Mong
Journal:  Horm Behav       Date:  2015-10-20       Impact factor: 3.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.